No sign of anthrax illness after CDC lab incident

June 30, 2014 by Mike Stobbe

Officials say there are no signs anyone got sick from anthrax after a lab safety problem at the Centers for Disease Control and Prevention.

Earlier this month, the CDC said dozens of workers at three labs in Atlanta may have been accidentally exposed to anthrax.

But on Monday, CDC officials said have not been found on surfaces in the labs and it's not clear that any dangerous anthrax was released.

About 60 workers were offered antibiotics and vaccinations as precautionary treatment. The CDC says about half can now stop taking the medication.

A CDC internal report on what went wrong is expected later this week. Earlier, the federal agency said samples used in research hadn't been sterilized as expected.

Explore further: Dozens of US workers taking anti-anthrax drugs

Related Stories

Dozens of US workers taking anti-anthrax drugs

June 20, 2014

The U.S. Centers for Disease Control and Prevention says at least 52 workers are taking antibiotics as a precaution because of a lab safety problem that may have accidentally exposed them to anthrax.

US probes lab workers' possible anthrax exposure (Update)

June 19, 2014

Some workers at the U.S. Centers for Disease Control and Prevention may have been accidentally exposed to dangerous anthrax bacteria this month because of a safety problem at some of its labs in Atlanta, the federal agency ...

Rare anthrax case diagnosed in Minnesota

August 10, 2011

Minnesota health officials said Tuesday they are investigating a rare case of anthrax inhalation linked to exposure to the dreaded bacteria in the natural environment.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.